Authors: Paltiel, O Avitzour, M Peretz, T Cherny, N Kaduri, L Pfeffer, RM Wagner, N Soskolne, V

Citation: O. Paltiel et al., Determinants of the use of complementary therapies by patients with cancer, J CL ONCOL, 19(9), 2001, pp. 2439-2448

Authors: Barak, V Nisman, B Hubert, A Lyass, O Kaduri, L Peretz, T

Citation: V. Barak et al., Prognostic efficacy of TPS in breast cancer, J TUMOR M, 15(3), 2000, pp. 171-176

Authors: Kaduri, L Gibs, M Hubert, A Sagi, M Heching, N Lerer, I Uziely, B Weinberg, N Abeliovich, D Peretz, T

Citation: L. Kaduri et al., Genetic testing of breast and ovarian cancer patients: clinical characteristics and hormonal risk modifiers, EUR J OB GY, 85(1), 1999, pp. 75-80

Authors: Hubert, A Peretz, T Manor, O Kaduri, L Wienberg, N Lerer, I Sagi, M Abeliovich, D

Citation: A. Hubert et al., The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer, AM J HU GEN, 65(3), 1999, pp. 921-924